CNS Drugs Flashcards
Zolpidem
Z-Drug. Commonly associated with sleep related behaviors. Short duration of action.
Atomoxetine Indications
ADHD. Especially in addicts (doesn’t cause euphoria).
Parkinson’s Pathophysiology
Caused by a loss of DA neurons in the nigrostriatal system. Treatment must balance Ach and DA.
Cholinesterase Inhibitors MOA
Increase Ach in the nerve terminals. May slow the progression of Alzheimer’s.
Mepivacaine
Amide LA. Intermediate duration of action.
Eszopiclone
Z-Drug. Long half life. Used for long-term treatment.
Secobarbital
Barbituate
Smoking Cessation
Bupropion will treat nicotine craving.
DOC for Bipolar Disorder
Lithium
TCA MOA
Inhibit re-uptake of NE and 5HT. Also blocks alpha, histamine and Ach receptors. Dirty drugs!
Galantamine
Cholinesterase Inhibitor used in Alzheimer’s
Tigabine Indications
Adjunct for partial seizures.
Metratazpine MOA
Blocks presynaptic alpha 2 receptors. Increases the release of NE and 5HT.
Citalopram.
SSRI. DOC for depression. Low incidence of drug interactions.
Z-Drugs MOA
Sedative-hypnotics. Bind the GABA receptor to increase GABA mediated inhibition.
Alcohol MOA
Binds to GABAa receptrs to increase Cl influx and enhance GABA (inhibitory) transmisison. Increases beta-endorphins in the mesolimbic pathway.
Cocaine effects
CNS stimulant. Increased SNS tone. Alertness, euphoria, hyperactivity, tachycardia, vasoconstriction, HTN, hyperprexia.
Midazolam
Very short-acting Benzodiazepine. Used for anxiety disorders and short surgical procedures as anesthesia.
DOC for Partial Seizures
Carbamazepine
Vigabatrin Indications
Refractory complex partial seizures. West’s syndrome.
Carbamazepine Indications
DOC for partial seizures. Also used for Trigeminal neuralgia, TC seizures and Refractory cases of Bipolar disorder.
Disulfuram (antabuse) MOA
Inhibits aldehyde dehydrogenase. Causes build up of acetyldehyde (flusing, nausea, HA).
Ropinirole
DA D2 agonist. Used as monotherapy in mild Parkinson’s. Can cause sudden sleep during the day.
Korsakoff’s psychosis
Chronic disabling memory loss
Memantine
NMDA receptor antagonist, reduces excitotoxic effects of glutamate and slows degerneration. Used in the late stages of Alzheimer’s in combination with a Cholinesterase Inhibitor.
Lamotrigine Indications
Partial seizures, Bipolar Disorder (prevents relapse). May be effective at treating myoclonic and absence seizures in children.
Carbamazepine SE
Diplopia, ataxia, high risk of SJS, Teratogenic.
Valproic Acid Indications
Second line treatment of absence seizures. Myoclonic seizures, bipolar disorder (rapid cycling), Migraine prophyaxis, mixed seizures.
Levodopa (L-dopa) Contraindications
Psychosis, Cardiac disease, malignant melanoma. Don’r use with MAOIs (HTN crisis).
Pramipexole
DA D2 agonist. Used as monotherapy in mild Parkinson’s. Can cause sudden sleep during the day.
Olanzapine (Zyprexa)
Atypical Antipsychotic. Can also be used in bipolar disorder. Similar to clozapine without the risk of agranulocytosis. EPS is very rare. Contraindicated in DM due to hyperglycemia.
PCP/Ketamine
NMDA receptor antagonists. Developed as general dissociative anesthetics. Cause analgesia accompanied by aggression. Often produces psychosis (treat with haloperidol).
Botulinum Toxin
Direct acting muscle relaxant. Inhibits Ach release from the nerve at the junction. Very toxic in large amounts.
Amitriptyline
TCA. Tertiary amine (primarily 5HT uptake).
Nigrostriatal DA Pathway
SN to the Striaturm. Motor. Parkinson’s (not enough DA) and the side effects of many antipsychotics.
Naltrexone Indications
Treatment of alcoholism and opiod addiction. Decreases craving.
Baclofen SE
Drowsiness, weakness. Respiratory depression with intrathecal administration (can reduce other SE and increase treatment).
Topiramate Indications
Partial and TC seizures. Migraine prevention.
Opiod MOA
Closes voltage gated Ca channels on presynaptic nerve terminals to decrease neurotransmitter release and neuronal activity. Decreases glutamate from the dorsal horn or the spinal cord to the brain. Mu receptors also open K channels to hyperpolarize the cell.
Alcohol Withdrawal Treatment
Hydration. Diazepam or chlordiazepoxide to prevent seizures/DTs. Lorazepam to treat seizures. Phenytoin is second line to treat seizures.
Pentazocine MOA
Mixed Opiod. Kappa agonist (dysphoria) and partial Mu agonist.
DOC for Depression
Citalopram
Topiramate MOA
Anti-convulsant. Blocks Na channels to potentiate GABA and block glutamate.
SNRI Indications
Depression, neuro pain, post menopausal hot flashes. Have more side effects than SSRIs.
Buproprion Contraindications
History of seizures.
Dantrolene
Direct acting Muscle Relaxant. Inhibits Ca release by blocking the RyR1 channel on the SR (interferes with excitation/contraction coupling). Used in neuroleptic malignant syndrome and malignant hyperthermia.
Vigabatrin SE
Visual field problems and retinal damage.
Gabapentin Indications
Adjunct use for partial and TC seizures. Neuropathic pain and Bipolar Disorder (rapid cycling).
Clonazepam MOA
Benzodiazapine. Stimulates GABA.
Ethosuximide Indications
DOC for absence seizures.
Buproprion Indications
Refractory depression (combined with SSRIs), ADHD, Alcoholism, smoking cessation (extended release). Causes less sexual dysfunction than the other antidepressants.
Trazodone Indications
Sleep aid and pain. Not useful in depression.
Amantadine
Antiviral that increases DA transmissioin and is used to treat early/mild cases of parkinson’s or as an adjunct to other treatment . Can cause livedo reticularis (red/blue spotting of skin).
Imipramine
TCA. Tertiary amine (primarily 5HT).
Oxymorphone
Moderate Opiod. Similar to oxycodone but doesn’t need to be activated by CYP2D6.
GHB
GABA receptor weak agonist. Developed as general dissociative anesthetics. Used as date rape drugs.
Carbamazepine MOA
Anticonvulsant. Blocks Na channels (decreases glutamate)
Amide Metabolism
Metabolized via CYP 450s. Can cause toxicity in patients with liver disease. Excreted by the kidneys.
PTSD Treatment
Anti-Depressants
Atomoxetine MOA
Selective NE reuptake inhibitor.
Gabapentin MOA
Anti-convulsant. GABA analogue.
Phenytoin/Fosphenytoin SE
Gingival hyperplasia. Risk of SJS. Teratogenicity.
Methanol Poisoning Treatment
Fomepizole (alcohol dehydrogenase inhibitor) can also use ethanol.
Meperidien (demerol) SE
Renal failure (don’t use longer than 48 hours), Seizures (due to metabolite normeperidine), Tachycardia. MAOI: serotonin syndrome. No antitussive effects.
Antipsychotic Drug Interactions
Sedative-Hypnotics: Increased Sedation Smoking: Induces CYP450s
Naltrexone MOA
Opiod receptor antagonist. Reduces craving. Long-acting.
SNRI MOA
Inhibits NE and 5HT reuptake
Fluphenazine
Classical Antipsychotic. Selective for DA D2 receptors. Less anticholinergic effects so higher risk of EPS.
Meperidien (demerol) MOA
Opiod. Mu agonist plus NE/5HT reuptake inhibitor. Also blocks muscarinic receptors.
Diazepam
Long- acting Benzodiazepine. Used in anxiety disorders, status epilepticus, alcohol/barbituate withdrawal (prevents seizures) and as a muscle relaxant
Ester Metabolism
Metabolized via butyrulcholinesterases in the plasma. Shorter duration of action and increased systemic toxicity. excreted by the kidneys. Has PABA as a metabolite which can cause allergic reactions.
Donepezil
Cholinesterase Inhibitor used in Alzheimer’s
Levetricetam SE
Dizziness, ataxia, asthenia (weakness), minimal drug interactions.
Hydromorphone
Strong opiod
Morphine
Strong Opiod. Severe pain. Injected. Associated with itching and vomiting.
Trazodone MOA
Anti-depressant. 5HT receptor antagonist.
Chlorpromazine MOA
Classical antipsychotic. Blocks DA D2 receptors but also alpha adrenergic and Ach receptors.
Rasagiline SE
Causes insomnia (take in the morning). Don’t use with Merperidine (stupor, rigidity, agitation) or TCA/SSRIs (serotonin syndrome).
Benzocaine
Ester LA. Topical use only. Pka=3.5 so always in nonionized form.
Acute Alcohol Toxicity Presentation
Emesis, stupor, coma, respiratory depression, electrolyte imbalances, hypothermia, decreased BP and CO.
Diazepam MOA
Centrally acting muslce relaxant (benzodiazepine). GABAa medicated presynaptic inhibition of the spinal cord. Also used in anxiety disorders, status epilepticus, alcohol/barbituate withdrawal (prevents seizures)
Tramadol Drug interactions
Serotonin syndrome if combined with MAOIs, TCAs, SSRIs/ Seizures: antidepressants.
Barbituates SE
Low margin of safety! Drowsiness, respiratory depression. Paradoxical excitement. Causes euphoria (drug of abuse) Supra-additive effect with alcohol.
Methamphetamines
Increases the release of DA and NE in the basal ganglia.. Rapid physical and psychological dependence. Cardiac toxicity, odor (hyperthermia), meth mouth, meth bugs.
Lithium MOA
Suppresses second messengers. Not metabolized. Excreted by the kidneys.
Fluoxetine
SSRI. Inhibits CYP450 (drug interactions). Inhibits conversion of codeine to morphine. Impairs BGL in DM.
D2 agonist Side effects
Anorexia, N/V, GI upset, Dyskinesias, mental disturbance, decreased prolactin.
Thopental
Barbituate. Used for induction of anesthesia.
SSRI Drug Interactions
MAOIs: Serotonin syndrome St. Johns Wort: Serotonin syndrome Opiods: Fluoxetine inhibits the conversion of codeine to morphine. Tramadol: inhibits 5HT reuptake and can lead to seizures and serotonin syndrome.
Nitrous Oxide
Used as an inhalant. Chronic use causes peripheral neuropathy. Frequently abused by dentists.
Classic Antipsychotics MOA
“neuroleptics.” Block DA D2 receptors. Target the mesolimbic system so only alleviates positive symptoms.
Mesolimbic DA Pathway
From the VTA to the Limbic system. Emotion. Too much DA causes the positive symptoms of schizophrenia.
Cocaine overdose
V-tach and V-fib. Strokes, bleed, seizures.
Pentazocine Indications
Moderate pain. Useful in addicts (low abuse potential).
Fetal Alcohol syndrome
microceophaly, mental retardation, poor coordination, flat face, joint abnormalities, heart defects, impaired immune system.
Apomorphone
DA D2 agonist. Used as “rescue” for the on/off phenomenon in successful L-dopa therapy. Caused N/V give antiemetic (trimethobrinzamide) beforehand.
Metratazpine Indications
None of the side effects associated with SSRIs (blocks 5HT in other places). Useful in depression mixed with insomnia or anxiety.
Methadone Indications
Treatment for addicts (prevent withdrawal) and long term pain control.
Phenelzine
MAOI. Inhibits MAO-A and MAO-B. Drug of last choice for depression. Don’t eat dietary tyramine (HTN crisis).
Lidocaine
Amide LA. Rapid onset. Used for infiltrative and epidural blocks. Not for spinal blocks (risk of TNS). Also used as an anti arrhythmic.
Venlaxfaxine
SNRI. May increase BP.
Development of Opiod Tolerance
Occurs rapidly. NMDA antagonists may decrease the development of tolerance. No tolerance develops to miosis, constipation or seizures.
Ethosuximide MOA
Anti-convulsant. Inhibits T-type Ca channels
Pharmacokinetic Alcohol Tolerance
Increased Alcohol metabolism because CYP2E1 is induced.
Benzodiazepines and Alcohol
Supra additive effect.
SSRI MOA
Selectively inhibit 5HT reuptake. Takes 2-3 weeks to have effects.
Dextromethorphan MOA
Antitussive Opiod. Blocks NMDA and decreases 5HT reuptake.
Dextromethorphan Indications
Cough suppression. Don’t’ use with MAOIs (serotonin syndrome)
Levodopa (L-dopa) SE
Has peripheral effects of N/V. Effectiveness will decrease over time. Has no effect on progression.
Benzodiazepines MOA
CNS depressant. GABAa agonist and increases the affinity for GABA (needs GABA) has ceiling effect.
Methadone MOA
Opiod. Strong mu agonist that also blocks NMDA and NE/5HT reuptake. Long duration of action. Decreased tolerance.
Cholinesterase Inhibitors SE
N/V, diarrhea, stomach cramps.
Desipramine
TCA. Secondary amine (primarily NE)
Duloxetine
SNRI. Hepatotoxicity.
Quetiapine (Seroquel)
Atypical Antipsychotic. Used to promote sleep and for sleep maintenance. Similar to clozapine without risk of agranulocytosis. Very sedating. Does not elevate prolactin levels.
SSRI SE
Mild compared to the TCAs. GI, weight change, CNS stimulation, Sexual dysfunction.
Ramelteon Indications
Resets sleep-wake cycle. Good for use in addicts.
Valproic Acid MOA
Anti-convulsant. Blocks Ca channels, Na channels, and may enhance GABA activity.
Cocaine as LA
Ester LA. Inhibits Na channels secondary to effects on increases DA in the CNS. Used topically. Decreases dental bleeding.
Clonazepam Indications
Absence and myoclonic seizures. West’s syndrome.
Levodopa (L-dopa) Indications
Treats Parkinson’s by improving bradykinesia for the first 3-4 years.
Effects of Opiods
Analgesia (develop tolerance), sedation, euphoria or dysphoria, histamine release (itching), emesis (esp. morphine), Antitussive (codeine and dextromethorphan), respiratory depression (useful in pulmonary edema), elevated intracranial pressure, Miosis (no tolerance), truncal rigidity (fentanyl), CONSTIPATION (no tolerance) Difficulty urinating.
Z-Drugs Indications
Insomia. Sedation with no anxiolytic, anticonvulsant or muscle relaxant properties.
Phenytoin/Fosphenytoin MOA
Anticonvulsants. Prolongs inactivation of Na channels (decreases glutamate).
Nalaxone
Opiod antagonist. Short duration of action. DOC for opiod overdose. Inject until pupils dilate.
Benzodiazepines Contraindications
Eldery, Sleep apnea, Pregnancy. Avoid abrupt withdrawla (rebound insomnia/anxiety).
Topiramate SE
Acute myopia and glaucoma.
Alprazolam
Intermediate-acting Benzodiazepine.
Phenobarbital
Barbituate. Anticonvulsant (partial seizures and TC seizures). HUGE Inducer CYP 450s.
Ramelteon MOA
Sedative-hypnotic. Melatonin analogue. No GABA effect.
Pentobarbital
Barbituate
Aripiprazole (Abilify) SE
Decreased esophageal motility. Low risk of EPS.
Carisoprodol
Acute local muscle relaxant. Metabolized to meprobamate (similar to barbituates) drug of abuse (caution in addicts).
Z-Drugs SE
Large margin of safety. Sleep related behaviors. Elderly may have confusion/memory loss. Rebound insomnia with abrupt withdrawal.
Entacapone
COMT inhibitor. Inhibits DA and L-dopa metabolism. Increases the pool of L-dopa available for the drain. Causes an orange color in the urine.
Acamprosate Indications
Treatment of Alcoholism. Decreases craving without liver toxicity.
MAOIs SE
Orthostatic hypotension, weight gain, insomnia.
Risperidone (Risperdal)
Atypical Antipsychotic. First line for psychosis. EPS and TD are rare.
Nortriptyline
TCA. Secondary amine (primarily NE)
Codeine MOA
Antitussive opiod. Has to be metabolized by CYP2D6 and converted into morphine.
Flumazenil Indications
Reverses effects of Benzodiazepine. Especially used to reverse Midazolam in surgical procedures.
DOC for absence seizures
Ethosuximide
DOC for Status Epilepticus
Diazepam
Clozapine
Atypical Antipsychotic. Last to choose due to the risk of agranulocytosis (have to monitor CBC closely). EPS and TD are very rare.
Ropivacaine
Amide LA. Long duration of action. S-enantiomer of bupivacaine (better clearance and less cardiac issues). Causes vasoconstriction.
Tuberoinfundibular DA Pathway
The hypothalamus to the pituitary (prolactin). Causes the side effects of many antipsychotics.
TCA Drug Interactions
Metabolized by CYP2D6 MAOIs: Serotonin Syndrome. Potentiate the sedative effects of alcohol and CNS depressants. Potentiate anticholinergic drug effects.
Alcohol Metabolism
Zero order (Rate is independent of concentration). Alcohol dehydrogenase is major enzyme. Secondary: MEOS and CYP2E1 (increases Acetaminophen toxicity), Induced with chronic consumption.
Selegiline
MAOI. Only inhibits MAO-B. Increases DA in the brain. Used in Parkinson’s disease.
DOC for Anxiety
Benzodiazepines
Rivastigmine
Cholinesterase Inhibitor used in Alzheimer’s
Lamotrigine Drug Interactions
Half life if DOUBLED with valproic acid.
Procaine
Ester LA. Short duration of action. Used for diagnostic nerve blocks.
Ethosuximide SE
Hiccups, SJS.
Fosphenytoin
Injectable version of phenytoin.
Temazepam
Benzodiazepine. Used for anxiety disorders and insomnia.
Tizanidine
Centrally acting muscle relaxant. Alpha 2 receptor agonist. Used for muscle spasm with limited muscle weakness. Very sedating.
Acamprosate MOA
Structural analogue of GABA. Restores balance between GABA and Glutamate.
Metratazpine SE
Blocks histamine (drowsiness).
Bupivacaine
Amide LA. Long duration of action. Used as epidural for labor/delivery. More potent sensory than motor block. High cardiotoxicity
Rasagiline MOA
MAOI that inhibits DA metabolism especially by MAO-B in the CNS to increase DA in the striatal pathway.
MAOIs MOA
Irreversibly inhibit MAO which metabolizes NE, DA and 5HT. MAO-A is in the CNS and periphery. MAO-B selectively metabolizes DA in the CNS.
Levetricetam Indications
Partial and TC seizures. Also used for myoclonic seizures.
Extrapyrimidal Symptoms (EPS)
Common side effect of antipsychotics (primarily classical). Due to blocking of the nigrostriatal DA pathway. Parkinson’s like side effects (tremor, dyskinesia, rigidity). Treat with an anticholinergic like benztropine to correct the imbalance of DA and Ach.
MAOI Drug interactions
Serotonin syndrome with: meperidine, dextromethorphan, TCAs, SSRIs. Tramadol: Hyperpyrexia OTC cold meds (sympathomimetics): Severe HTN
Alzheimer’s Pathophysiology
Degeneration of cholinergic neaurons. Beta-amyloid plaques and tau proteins.
Trihexyphenidyl
Muscarinic receptor antagonist, restores Ach and DA balance. Used as an adjunct to improve rigidity and tremor.
Cocaine MOA
Inhibits DA reuptake and secondarily inhibits Na channels.
Lamotrigine MOA
Anti-convulsant. Inactivation of Na channels.
Baclofen MOA
Centrally acting muscle relaxant. GABAb agonist (opens K channels causing hyperpolarization) and decreases presynaptic Ca influx (decreases neurotransmitter release).
Tigabine MOA
Anti-convulsant. Inhibits the reuptake of GABA via GAT1. Short half life. Few drug interactions.
DOC for restless leg syndrome
Ropinirole
Reward Pathway
Mesolimbic DA pathway. VTA to the NAc to the prefrontal cortex. All drugs of abuse release DA in the accumbens.
Buprenorphine Indications
Maintenance treatment of opiod addiction (decreases cravings).
Effects of Alcohol
CNS: disinhibition, mild euphoria, depressant and sedation. Smooth Muscle: Vasodilation (hypothermia) Heart: Depression of myocardial contractility Kidney: Decreases ADH (Diuresis).
Lorazepam
Intermediate-acting Benzodiazepine. Used for anxiety disorders and status epilepticus.
Barbituate Overdose and Treatment
Coma, respiratory depression. Treated by supportive care and alkalizing the urine. Don’t use stimulants.
Pharmacodynamic Alcohol Tolerance
Down- regulation of GABA receptors and Up-regulation of NMDA receptors (blackout amnesia). Causes Withdrawal symptoms.
LSD
Act on 5HT receptors in the brain. Doesn’t cause addiction. Euphoria, visual hallucinations, synesthesia.
Trazodone SE
Sedations, priapism, liver failure.
Bath Salts
Synthetic Cannabinoid agonist. Has psychoactive properties. Elevated HR and BP.
Flurazepam
Long-acting Benzodiazepine. Used for anxiety disorders, alcohol/barbituate withdrawal and insomnia.
Prochlorpromazine
Classical antipsychotic. Same as Chlorpromazine. Used as an antiemetic.
Tramadol MOA
Moderate Opiod. Weak mu agonist. Inhibits NE/5HT reuptake.
Parkinson’s Presentation
Bradykinesia (slow movement), Muscle rigidity, resting tremors, impairment of posture balance and gait.
Cocaine long term side effects
Overall reduction in brain activity. Sever craving. Physical and physiological dependence.
Etidocaine
Amide LA. Intermediate duration of action. Inverse differential block (causes motor block before or even without sensory block).
Hydrocodone
Moderate Opiod. Activated by CYP2D6 (variable metabolizers.
Buspirone Indications
Relieves anxiety with no sedation. Good to use in addicts.
Flumazenil Contraindications
History of seizures or chronic alcohol abuse.
Paroxetine
SSRI. Used for OCD and Social Anxiety.
Flumazenil MOA
Benzodiazepine antagonist
Neuroleptic Malignant Syndrome (NMS)
Life threatening side effect. Muscle rigidity, hyperprexia. Caused by blockade of DA D2 receptors in the striatum and hypothalamus. Treat with dantrolene.
Ziprisadone (Geodon)
Atypical Antipsychotic. Used for tourette’s and acute mania. Prolongs QT interval and causes sedation.
Nicotine
Activates nicotinic receptors in the CNS increases 5HT and DA. Intense psychological and physical dependence. Induces CYP450s.
Fentanyl
Strong, very potent opiod. Used in short surgical procedures. Truncal rigidity (rapid IV).
Levetricetam MOA
Anti-convulsant. Binds synaptic vsicular protein (SV2A) to decrease glutamate and increase GABA release.
Lithium SE
Diabetes insipidus. Small therapeutic window (Extremely toxic in overdose).
Chlordiazepoxide
Long-acting Benzodiazepine. Used in anxiety disorders and alcohol/barbituate withdrawal (prevent seizures).
Amphetamine MOA
Increase release of DA by reversing DA transport through the DAT.
Effect of Chronic Alcohol Abuse
Liver: cirrhosis, alcoholic hepatitis, Liver cancer Malnutrition: Folate and Thiamine CNS effects, Cardiomyopathy, Mild Anemia, Sexual dysfunctioin, respiratory infections (immunosuppressed), Skeletal muscle atrophy, hypothermia, teratogenicity (fetal alcohol syndrome)
General Side Effects of Antipsychotics
Decreased seizure threshold, Anticholinergic effects, EPS, Tardive Dyskinesia, NMS.
St. John’s Wort Drug Interactions
Don’t combine with other anti-depressants due to serotonin syndrome.
TCA SE
Caused by blocking alpha (cardiac depression, arrhythmias), histamine (drowsiness) and Ach (antichol effects) receptors. Weight gain. Analgesia. SIADH. Sexual dysfunction. Decreased seizure threshold. No euphoria (low abuse potential). Can be used in pregnancy.
Bromocriptine
Ergot derivative that acts as a DA D2 agonist. Side effect of erythromelalgia. Can be used to decrease craving for cocaine.
Chloral Hydrate
Sedative-Hypnotic. Not highly recommended (low margin of safety) but extremely cheap. Often used in nursing homes.
Lamotrigine SE
Dizziness, HA, N/V, SJS, rash, teratogenic.
Barbituates Contraindications
Pulmonary insufficiency, Porphyria (increases porphyrin synthesis).
Levodopa (L-dopa) MOA
Replacement therapy for Parkinson’s. L-dopa can cross the BBB where it is converted into DA (only 1-3% gets into the brain).
Barbituates MOA
CNS depressant (hypnosis). GABAa agonist. Binds the receptor and increases the duration of GABA action. Occurs Independent of GABA. No ceiling effect (Low margin of safety).
Metaxalone methocarbamol
Acute local muscle relaxant.
Zaleplone
Z-Drug. Short duration of action.
Benzotropine
Muscarinic receptor antagonist, restores Ach and DA balance. Used as an adjunct to improve rigidity and tremor.
TCA Indications
Chronic TMJ pain, Fibromyalgia, Depression (last drug of choice).
Articaine
Amide LA that also has an ester group so metabolized via plasma esterases. Used commonly in dentistry.
Buproprion MOA
Anti-depressant. Inhibits DA reuptake (little NE and 5HT).
Tardive Dyskinesia (TD)
Side effect of antipsychotics (least likely to occur with clozapine and olanzapine) especially after long term treatment. Chreiform, uncontrolled jerky movements.
Methanol Poisoning Presentation
Visual disturbances (being in a snow storm), formaldehyde on breath. Severe metabolic acidosis.
Wernicke-korsakoff syndrome
paralysis of eye muscles, ataxia, confusion, coma and dearh. Due to thiamine deficiency.
Disulfuram (antabuse) Indications
Treatment of alcoholism. Not often used. Dangerous.
Mesocortical DA Pathway
VTA to the frontal cortex. Cognition and Emotion. Not enough DA causes the negative symptoms of schizophrenia.
Prilocaine
Amide LA. Immediate duration of action. Has the highest rate of clearance of the amides. Risk of methemoglobinemia.
Local Anesthetics Transport Across the Membrane
Local Anesthetics are weak bases. Must be nonionized to cross the cell membrane. The closer their Pka is to 7.4 the higher concentration is nonionized so the faster it is transported. Inflammation (more acidic) decreases onset of action and bicarb increases the onset of action.
Atypical Antipsychotics MOA
Blocks 5HT2a and DA D2 and D4 receptors. Targets the mesocortical and mesolimbic systems. Alleviates both positive and negative symptoms.
Carbidopa MOA
Inhibits dopa-decarboxylase in the periphery. Combined with L-Dopa to decrease the peripheral effects (N/V).
Treatment of Anxiety in Children
Anti-Depressants
Lithium Drug interactions
NSAIDs: Increase toxicity. Diueretics: Alter clearance. Competes with Na for reabsorption in the kidney. Decreased Na causes increased lithium toxicity. Increased Na causes an increased excretion of lithium. Increased Lithium causes hyponatremia.
Phenytoin/Fosphenytoin Metabolism
Metabolized by and induces and inhibits CYP450s. First order elimination at low doses, Zero order elimination at therapeutic doses.
Carbidopa SE
Postural hypotension, Arrhythmias, HTN, Dyskinesias
Aripiprazole (Abilify) MOA
Atypical Antipsychotic. Partial agonist for DA D2 and 5HT1a. Antagonist for 5HT2a. “DA system stabilizer” acitvate receptors when DA is too low and blocks them if DA is too high.
Acute Alcohol Toxicity Treatment
Manage respirations and prevent emesis. Seizures: Lorazepam or phenytoin.
Local Anesthetics General MOA
Block Na channels to inhibit neuronal firing. Higher affinity for channels in activated or inactivated state, not in resting state. Block in more effective in rapidly firing axons. Elevated Ca will diminish the block and elevated K will increase the block.
Sertraline
SSRI. Preferred in the elderly. Least drug interactions of the SSRIs.
Cocaine Addiction treatment
Bromocriptine can decrease craving.
Ramelteon SE
Drowsiness, dizziness, nausea. Additive sedation with alcohol.
Buprenorphine MOA
Mixed Opiod. Partial Mu agonist with some Kappa. Often mixed with naloxone (inhibits effects if injected).
SSRI Indications
Depression, panic disorder, bulimia, alcoholism, and depression in children.
Valproic Acid SE
Alopecia, hepatotoxictiy, teratogenic.
Alcohol Withdrawal Presentation
Mild anxiety, irritability, insomnia, nausea, tachycardia. Hallucinations, DTs, seizures, hypotension, arrhythmias.
Buspirone MOA
Sedative-hypnotic. Partial agonist at postsynaptic 5HT (inhibits signaling) and full agonist at presynaptic 5HT (decreases release of 5HT).
Acute Local Muscle Relaxant MOA
Acts at the brain stem to decrease neuronal activity in the spinal cord.
Gabapentin Metabolism
First order elimination. Excreted by the kidneys. Negligible drug interactions.
MDMA (ecstasy)
Increases 5HT by blocking reuptake and stimulating 5HT receptors. Not addictive because doesn’t effect DA. Leads to hyperthermia and dehydration. Can have persistent memory loss.
Chlorpromazine SE
High anticholinergic effects so low risk of EPS. Retinal deposits and decreased seizure threshold.
Phenytoin/Fosphenytoin Indications
Partial and TC seizures.
Tetracaine
Ester LA. 16x more potent that procaine. Ophthalmologic use (retrobulbar).
Oxycodone
Moderate Opiod. Activated by CYP2D6 (variable metabolizers.
Dibucaine
Dibucaine number test to determine butyrylcholinesterase activity to identify mutations or deficiencies.
Marijuana (THC)
Targets presynaptic cannabinoid (CB1) receptors and inhibits neurotransmitter release (Ach and glutamate). No physiologic dependence but psychological dependence is possible. Amotivational syndrome.
Naltrexone SE
Liver damage. Don’t use in patients with liver failure. Will precipitate with chronic opiod users.
Opiod Drug Interactions
Seadtive-hypnotics: CNS and respiratory depression Antipsychotics: sedation and respiratory depression MAOIs: meperidine and dextro can cause serotonin syndrome. Fluoxetine: inhibits metabolsim of coedine to morphine.
Cyclobenzaprine
Acute local muscle relaxant. Has antimuscarinic action so causes sedation.
Oxazepam
Intermediate-acting Benzodiazepine.
Vigabatrin MOA
Anti-convulsant. Irreversibly inhibits AB transaminase (GABA-T) to decrease GABA metabolism.
Benzodiazepines SE
CNS depression (tolerance will develop), paradoxical excitement (elderly), Sleep related behaviors. High abuse potential.
Halperidol
Classical Antipsychotic. Injected for acute psychosis. No anticholinergic effects so high risk of EPS.